SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017982
Filing Date
2019-05-09
Accepted
2019-05-09 16:11:27
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q phas-10q_20190331.htm 10-Q 1683135
2 EX-31.1 phas-ex311_7.htm EX-31.1 16763
3 EX-31.2 phas-ex312_8.htm EX-31.2 16748
4 EX-32.1 phas-ex321_6.htm EX-32.1 7579
5 EX-32.2 phas-ex322_9.htm EX-32.2 7579
  Complete submission text file 0001564590-19-017982.txt   4793634

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT phas-20190331.xml EX-101.INS 712961
7 XBRL TAXONOMY EXTENSION SCHEMA phas-20190331.xsd EX-101.SCH 41542
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phas-20190331_cal.xml EX-101.CAL 40226
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phas-20190331_def.xml EX-101.DEF 125086
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE phas-20190331_lab.xml EX-101.LAB 334975
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phas-20190331_pre.xml EX-101.PRE 241078
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 19810643
SIC: 2834 Pharmaceutical Preparations